Old Web
English
Sign In
Acemap
>
authorDetail
>
Yudan Shi
Yudan Shi
Guangzhou Institutes of Biomedicine and Health
Nuclear receptor
Chemistry
IC50
Inverse agonist
Pharmacology
2
Papers
22
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist.
2021
Journal of Medicinal Chemistry
Wu Xishan
Hui Shen
Yan Zhang
Chao Wang
Qiu Li
Cheng Zhang
Xiaoxi Zhuang
Chenchang Li
Yudan Shi
Yanli Xing
Qiuping Xiang
Jinxin Xu
Donghai Wu
Jinsong Liu
Yong Xu
Show All
Source
Cite
Save
Citations (1)
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable ROR gamma Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer.
2019
Journal of Medicinal Chemistry
Yan Zhang
Xishan Wu
Xiaoqian Xue
Chenchang Li
Junjian Wang
Rui Wang
Cheng Zhang
Chao Wang
Yudan Shi
Lingjiao Zou
Qiu Li
Zenghong Huang
Xiaojuan Hao
Kerry M. Loomes
Donghai Wu
Hongwu Chen
Jinxin Xu
Yong Xu
Show All
Source
Cite
Save
Citations (21)
1